[Optimal therapy of diabetic nephropathy: AVOID Study (Aliskiren in the evaluation of proteinuria in diabetes)]
- PMID: 19424672
- DOI: 10.1007/s00108-009-2391-1
[Optimal therapy of diabetic nephropathy: AVOID Study (Aliskiren in the evaluation of proteinuria in diabetes)]
Comment on
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy.N Engl J Med. 2008 Jun 5;358(23):2433-46. doi: 10.1056/NEJMoa0708379. N Engl J Med. 2008. PMID: 18525041 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
